ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Regent Pacific Receives HK$24.96 million After Clinical Trial Approval For FORTACIN(TM) Has Been Obtained
April 02, 2021Regent Pacific Group Limited, a specialist healthcare, wellness and life sciences investment group is pleased to announce that the Group has received a payment of US$3.20 million (approximately HK$24.96 million) before deduction of PRC withholding ... -
Sirona Biochem Receives $500,000 Milestone from Wanbang
August 30, 2018Sirona Biochem has received a $500,000 milestone payment from partner Wanbang Biopharmaceuticals for approval by the China Food and Drug Administration (CFDA) of the Phase I clinical trial for Sirona's SGLT-2 inhibitor.......
Pharma Sources Insight January 2025
